Michael Lyle

Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial.

Youwen Zhou, R. Bissonnette, C. Maari, 2010, Archives of dermatology.

A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors

C. Supuran, S. Dedhar, Philippe Bédard, 2020, American journal of clinical oncology.

Substituted 6-amino-4H-[1,2]dithiolo[4,3-b]pyrrol-5-ones: synthesis, structure-activity relationships, and cytotoxic activity on selected human cancer cell lines.

M. Alaoui-Jamali, J. Webster, Genhui Chen, 2007, Bioorganic & medicinal chemistry.

Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways

B. Durden, N. Merchant, A. Saluja, 2020, Cell Death & Disease.

Efficacy and safety of topical WBI‐1001 in patients with mild to moderate psoriasis: results from a randomized double‐blind placebo‐controlled, phase II trial

R. Bissonnette, S. Nigen, C. Maari, 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.